Neurological Disorder Diagnostics Market to Surpass US $20,129.5 Mn Threshold by 2026 - Coherent Market Insights
Global Neurological Disorder Diagnostics Market, by Technology (Imaging and In Vitro Diagnostics), by Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), by End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 10,774.6 Mn in 2017, and is projected to exhibit a CAGR of 7.3% over the forecast period (2018 – 2026), as highlighted...
View full press release